Saad B. Omer

Saad B. Omer

Director, Yale Institute for Global Health
Email verificata su yale.edu
Citato da 197270
Vaccines COVID-19 Influenza RSV Global Health
Edward Belongia

Edward Belongia

Marshfield Clinic Research Institute
Email verificata su marshfieldclinic.org
Citato da 27293
Vaccines Influenza RSV Infectious diseases
Richard Pebody

Richard Pebody

UKHSA
Email verificata su ukhsa.gov.uk
Citato da 26957
High Threat Pathogens Influenza COVID-19 RSV Vaccine preventable disease
Asuncion Mejias, MD, PhD, MsCS

Asuncion Mejias, MD, PhD, MsCS

Associate Professor of Pediatrics, Nationwide Children's Hospital
Email verificata su nationwidechildrens.org
Citato da 16803
Pediatric Infectious Diseases respiratory viral infections RSV COVID-19
Tina Hartert, MD, MPH

Tina Hartert, MD, MPH

Vanderbilt University School of Medicine, Vanderbilt University Medical Center
Email verificata su vumc.org
Citato da 16464
Asthma primary prevention RSV allergic rhinitis alpha-tocopherol
Manjusha Gaglani

Manjusha Gaglani

Pediatric
Email verificata su BSWHealth.org
Citato da 16300
Vaccine Influenza RSV SARS-CoV-2 Epidemiology
M. Gordon Joyce, PhD

M. Gordon Joyce, PhD

Chief, Structural Biology, HJF, WRAIR
Email verificata su eidresearch.org
Citato da 14991
Structural Vaccinology coronaviruses RSV Influenza
Qiu Sue Huang

Qiu Sue Huang

Institutute of Environmental Science and Research
Email verificata su esr.cri.nz
Citato da 11329
Influenza polio RSV non-polio enterovirus
Daniel M Weinberger

Daniel M Weinberger

Yale University
Email verificata su yale.edu
Citato da 10300
pneumococcus rsv vaccines impact evaluation real-world evidence
Meredith L. McMorrow

Meredith L. McMorrow

US Centers for Disease Control and Prevention
Email verificata su cdc.gov
Citato da 9441
RSV COVID-19 SARS-CoV-2 Influenza vaccines
1 - 10